Hospira Pain Meds Recalled

Report this content

Hospira, Inc. has issued a voluntary recall of one lot of its opioid pain medication cartridges over a report of overfill which may cause life-threatening overdose consequences.

The recall is being issued in full knowledge of the US Food and Drug Administration (FDA). The recalled glass cartridges are prefilled and meant for use with Carpuject Syringe system. The specifications are:

  • Hydromorphone Injection, USP, 2 mg/mL (C-II), 1 mL fill in 2.5 mL Carpuject™, NDC 0409-1312-30
  • Lot number - 12720LL
  • Expiration date - December 1, 2013
  • Distributed from March – May 2012

Overdosing on opiod pain killers such as hydromorphone can cause serious repercussions, such as slowed/suspended breathing, low blood pressure, and reduced heart rate/circulatory collapse.

The cartridges have been reported to be slightly overfilled than what the labels say. Although no occurrence of adverse events has been reported to date, end users and healthcare professionals have been notified not to use the affected lot of the drug in May, 2012.

If you or a loved one has been harmed by a dangerous drug, contact Sokolove Law today for a free legal consultation and to find out if a dangerous drug lawyer may be able to help you pursue legal action. For legal help, call (800) 581-6358.

Tags: